97 related articles for article (PubMed ID: 3916080)
1. Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.
Stevenson GT; Glennie MJ
Cancer Surv; 1985; 4(1):213-44. PubMed ID: 3916080
[TBL] [Abstract][Full Text] [Related]
2. Anti-idiotypic therapy of leukemias and lymphomas.
Stevenson FK; George AJ; Glennie MJ
Chem Immunol; 1990; 48():126-66. PubMed ID: 2403803
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for B cell malignancies involving idiotype-anti-idiotype interactions.
Stevenson FK; Stevenson GT
Int Rev Immunol; 1986 Jul; 1(3-4):303-33. PubMed ID: 3334051
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody therapy of lymphoid malignancy.
Lowder JN; Meeker TC; Levy R
Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318
[TBL] [Abstract][Full Text] [Related]
5. The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes.
Levy R; Meeker T; Lowder J; Levy S; Thielemans K; Warnke RA; Cleary ML; Sklar J
Symp Fundam Cancer Res; 1986; 38():261-8. PubMed ID: 3529276
[No Abstract] [Full Text] [Related]
6. Analysis of the interaction of antibodies with immunoglobulin idiotypes on neoplastic B lymphocytes: implications for immunotherapy.
Elliott TJ; Glennie MJ; McBride HM; Stevenson GT
J Immunol; 1987 Feb; 138(3):981-8. PubMed ID: 2433338
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
Kon S
Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417
[TBL] [Abstract][Full Text] [Related]
8. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.
Benvenuti F; Burrone OR
Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of expression of idiotopes recognized by a panel of monoclonal antibodies in normal serum immunoglobulin: use of a novel 4-stage ELISA assay.
Cachia PG; Pepper DS; Dewar AE; Krajewski AS
J Clin Lab Immunol; 1989 Apr; 28(4):195-200. PubMed ID: 2516872
[TBL] [Abstract][Full Text] [Related]
10. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy.
Lanier LL; Babcock GF; Lynes MA; Haughton G
J Natl Cancer Inst; 1979 Dec; 63(6):1417-22. PubMed ID: 316036
[No Abstract] [Full Text] [Related]
11. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
Qian GX; Fu SM; Solanki DL; Rai KR
J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
13. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
14. Anti-idiotypes in B-cell tumor therapy.
Miller RA; Lowder J; Meeker TC; Brown S; Levy R
NCI Monogr; 1987; (3):131-4. PubMed ID: 3493440
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM.
Perek Y; Hurwitz E; Burowski D; Haimovich J
J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103
[TBL] [Abstract][Full Text] [Related]
16. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
Hatzubai A; Maloney DG; Levy R
J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
[TBL] [Abstract][Full Text] [Related]
17. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
[TBL] [Abstract][Full Text] [Related]
18. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
Thielemans K; Maloney DG; Meeker T; Fujimoto J; Doss C; Warnke RA; Bindl J; Gralow J; Miller RA; Levy R
J Immunol; 1984 Jul; 133(1):495-501. PubMed ID: 6609992
[TBL] [Abstract][Full Text] [Related]
19. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation.
Stevenson FK; Gordon J
J Immunol; 1983 Feb; 130(2):970-3. PubMed ID: 6600259
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
